Tarsus Pharmaceuticals, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
TARS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
15440 Laguna Canyon Road, Irvine, CA

Insiders trading volume in the past year

Tarsus Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bobak R. Azamian President/CEO and Board Chair, Director $49.7M -$2.1M -4.04% Sep 24, 2025
Vivo Capital IX, LLC 10%+ Owner $49.4M May 5, 2022
Rtw Investments, Lp 10%+ Owner $40.3M May 7, 2021
Michael Ackermann Director $26.4M Jun 16, 2022
William J. Link Phd Director $8.15M -$1.55M -15.9% Sep 16, 2025
Seshadri Neervannan Chief Operating Officer $4.64M -$363K -7.26% Mar 18, 2025
Bryan Wahl General Counsel $3.21M -$464K -12.6% Mar 18, 2025
Dianne C. Whitfield Chief Human Resources Officer $2.94M -$321K -9.86% Mar 18, 2025
Aziz Mottiwala Chief Commercial Officer $2.76M -$1.27M -31.5% Jun 9, 2025
Jeffrey Farrow Chief Financial Officer and Chief Strategy Officer $2.13M -$728K -25.5% Jun 16, 2025
Elizabeth Yeu Lin Chief Medical Officer $2.07M -$41.3K -1.96% Jun 13, 2025
Leonard Greenstein Chief Financial Officer $1.19M Apr 20, 2023
Jose M. Trevejo Chief Medical Officer $914K Dec 20, 2023
Andrew D. Goldberg Director $791K Jun 12, 2025
Wendy L. Yarno Director $704K Jun 12, 2025
Scott W. Morrison Director $479K Sep 15, 2025
Bhaskar Chaudhuri Director $467K Jun 12, 2025
Katherine Goodrich Director $288K Jun 12, 2025
Rosemary A. Crane Director $202K Jun 24, 2024
Mark J. Holdbrook V.P., Clinical Affairs $194K Mar 17, 2023
Jason E. Tester Director, 10%+ Owner $110K Jun 15, 2021

Recent Insider Transactions by Companies or Individuals for Tarsus Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.